Matrix Biotech

Matrix Biotech offers an at-home testing platform that combines a mobile app, AI, and simple blood tests to measure biomarkers locally instead of relying on centralized labs. By running analysis close to the patient, Matrix Biotech is building a diagnostic workflow that can make testing up to 10x cheaper and 1000x faster, starting with a quantitative blood alcohol test that reached an 85% accuracy rate within two weeks of development.

Founded in 2025 by Krish Mendapara and Liam McNamara, Matrix Biotech builds on experience across Alzheimer’s therapeutics labs, BenchSci, computational genomics research, public health work with the Nigerian Health Ministry to prevent 15,000 COVID cases, and neuroscience labs that contributed to Nobel-winning discoveries. The team is focused on turning complex biomarker analysis into something you can do at home with a phone and a simple blood test, making fast, affordable, data-driven testing a normal part of everyday health.